Cargando…
Altered neurovascular coupling as measured by optical imaging: a biomarker for Alzheimer’s disease
Neurovascular coupling can be directly assessed by retinal vessel response to flickering light using optical imaging methods. The response is altered in a number of ocular and cardiovascular diseases. Whether it is altered in Alzheimer’s disease (AD) is investigated. Retinal vessel reaction to monoc...
Autores principales: | Kotliar, Konstantin, Hauser, Christine, Ortner, Marion, Muggenthaler, Claudia, Diehl-Schmid, Janine, Angermann, Susanne, Hapfelmeier, Alexander, Schmaderer, Christoph, Grimmer, Timo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635105/ https://www.ncbi.nlm.nih.gov/pubmed/29018233 http://dx.doi.org/10.1038/s41598-017-13349-5 |
Ejemplares similares
-
Decreased Vascular Pulsatility in Alzheimer’s Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography
por: Ortner, Marion, et al.
Publicado: (2019) -
Cerebrospinal fluid lactate levels along the Alzheimer’s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers
por: Zebhauser, Paul Theo, et al.
Publicado: (2022) -
Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex
por: Mehrabian, Shima, et al.
Publicado: (2015) -
Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2019) -
Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2020)